Connection

Prabhakar Baliga to Middle Aged

Back to Details
This is a "connection" page, showing publications Prabhakar Baliga has written about Middle Aged.
Prabhakar Baliga
Connection Strength
1.748
Middle Aged
  1. Facilitated Regional Collaboration and In-Hospital Surgical Complication. J Am Coll Surg. 2021 04; 232(4):536-543.
    View in: PubMed
    Score: 0.052
  2. Maintaining Equity and Access: Successful Implementation of a Virtual Kidney Transplantation Evaluation. J Am Coll Surg. 2021 04; 232(4):444-449.
    View in: PubMed
    Score: 0.052
  3. The non-directed living kidney donor: Why donate to strangers? J Ren Care. 2019 Jun; 45(2):102-110.
    View in: PubMed
    Score: 0.046
  4. South Carolina Surgical Quality Collaborative Colon Surgery Outcomes Vary by Age and Race. Am Surg. 2018 Aug 01; 84(8):1312-1313.
    View in: PubMed
    Score: 0.044
  5. Feasibility and Functional Testing for Frailty in Chronic Kidney Disease. Prog Transplant. 2018 09; 28(3):299-300.
    View in: PubMed
    Score: 0.043
  6. Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients. Ann Transplant. 2018 Feb 16; 23:119-128.
    View in: PubMed
    Score: 0.042
  7. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. J Am Coll Surg. 2018 04; 226(4):651-659.
    View in: PubMed
    Score: 0.042
  8. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938.
    View in: PubMed
    Score: 0.042
  9. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
    View in: PubMed
    Score: 0.041
  10. Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation. J Am Coll Surg. 2017 Apr; 224(4):585-592.
    View in: PubMed
    Score: 0.039
  11. Social Media Use Among Living Kidney Donors and Recipients: Survey on Current Practice and Potential. J Med Internet Res. 2016 12 20; 18(12):e328.
    View in: PubMed
    Score: 0.039
  12. Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg. 2017 Apr; 213(4):666-672.
    View in: PubMed
    Score: 0.039
  13. A patient navigator and education program for increasing potential living donors: a comparative observational study. Clin Transplant. 2016 05; 30(5):619-27.
    View in: PubMed
    Score: 0.037
  14. Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):613-620.
    View in: PubMed
    Score: 0.036
  15. Health literacy and kidney transplant outcomes. Prog Transplant. 2015 Mar; 25(1):85-90.
    View in: PubMed
    Score: 0.034
  16. Inclusion of dynamic clinical data improves the predictive performance of a 30-day readmission risk model in kidney transplantation. Transplantation. 2015 Feb; 99(2):324-30.
    View in: PubMed
    Score: 0.034
  17. African American patient knowledge of kidney disease: A qualitative study of those with advanced chronic kidney disease. Chronic Illn. 2015 Dec; 11(4):245-55.
    View in: PubMed
    Score: 0.034
  18. Variations in coping stages for individuals with chronic kidney disease: Results from an exploratory study with patient navigators. J Health Psychol. 2016 07; 21(7):1299-310.
    View in: PubMed
    Score: 0.034
  19. Development and testing of a disease-specific health literacy measure in kidney transplant patients. Prog Transplant. 2014 Sep; 24(3):263-70.
    View in: PubMed
    Score: 0.033
  20. The concept of a composite perioperative quality index in kidney transplantation. J Am Coll Surg. 2014 Apr; 218(4):588-97.
    View in: PubMed
    Score: 0.032
  21. Racial comparisons of everolimus pharmacokinetics and pharmacodynamics in adult kidney transplant recipients. Ther Drug Monit. 2013 Dec; 35(6):753-9.
    View in: PubMed
    Score: 0.032
  22. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. Clin Transplant. 2013 Sep-Oct; 27(5):732-41.
    View in: PubMed
    Score: 0.031
  23. Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation. Prog Transplant. 2013 Mar; 23(1):33-8.
    View in: PubMed
    Score: 0.030
  24. Improving the perioperative value of care for vulnerable kidney transplant recipients. J Am Coll Surg. 2013 Apr; 216(4):668-76; discussion 676-8.
    View in: PubMed
    Score: 0.030
  25. Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant. 2013 Mar; 13(3):796-801.
    View in: PubMed
    Score: 0.030
  26. Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes. Pharmacotherapy. 2012 Dec; 32(12):1053-60.
    View in: PubMed
    Score: 0.029
  27. Barriers facing patients referred for kidney transplant cause loss to follow-up. Kidney Int. 2012 Nov; 82(9):1018-23.
    View in: PubMed
    Score: 0.029
  28. Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients. Am J Med Qual. 2013 Mar-Apr; 28(2):103-12.
    View in: PubMed
    Score: 0.029
  29. Generic immunosuppression: deciphering the message our patients are receiving. Ann Pharmacother. 2012 May; 46(5):671-7.
    View in: PubMed
    Score: 0.028
  30. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1003-9.
    View in: PubMed
    Score: 0.028
  31. Case report: gastrointestinal hemorrhage caused by a pancreas transplant arteriovenous fistula with large psuedoanuerysm 9 years after transplantation. Transplant Proc. 2011 Dec; 43(10):4039-43.
    View in: PubMed
    Score: 0.027
  32. Potential differences in kidney allograft outcomes between ethnicities when converting to sirolimus base immunosuppression. Transplant Proc. 2009 Dec; 41(10):4131-7.
    View in: PubMed
    Score: 0.024
  33. Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients. Transpl Int. 2010 May 01; 23(5):500-5.
    View in: PubMed
    Score: 0.024
  34. Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation. Clin Transplant. 2010 Jan-Feb; 24(1):40-7.
    View in: PubMed
    Score: 0.023
  35. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. Transplant Proc. 2008 Dec; 40(10):3401-7.
    View in: PubMed
    Score: 0.022
  36. Racial differences in the living kidney donation experience and implications for education. Prog Transplant. 2007 Sep; 17(3):234-40.
    View in: PubMed
    Score: 0.020
  37. Use of bone health protocol to identify and prevent bone disease in kidney and pancreas transplant recipients. Ann Pharmacother. 2007 Jun; 41(6):944-50.
    View in: PubMed
    Score: 0.020
  38. Racial differences in coping with the need for kidney transplantation and willingness to ask for live organ donation. Am J Kidney Dis. 2006 Feb; 47(2):324-31.
    View in: PubMed
    Score: 0.018
  39. Transcatheter splenic artery occlusion for treatment of splenic artery steal syndrome after orthotopic liver transplantation. Cardiovasc Intervent Radiol. 2002 Jul-Aug; 25(4):300-6.
    View in: PubMed
    Score: 0.014
  40. Surgical Outcomes Improvement and Health Inequity in a Regional Quality Collaborative. J Am Coll Surg. 2022 04 01; 234(4):607-614.
    View in: PubMed
    Score: 0.014
  41. The Perioperative Patient Experience During COVID-19. Am Surg. 2022 Mar; 88(3):498-506.
    View in: PubMed
    Score: 0.014
  42. Acceptability of a Mobile-Health Living Kidney Donor Advocacy Program for Black Wait-Listed Patients. Int J Environ Res Public Health. 2021 08 04; 18(16).
    View in: PubMed
    Score: 0.013
  43. Virtual Crossmatching in Kidney Transplantation: The Wait Is Over. J Am Coll Surg. 2020 04; 230(4):373-379.
    View in: PubMed
    Score: 0.012
  44. Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. Clin Transplant. 2019 10; 33(10):e13701.
    View in: PubMed
    Score: 0.012
  45. Development and future deployment of a 5 years allograft survival model for kidney transplantation. Nephrology (Carlton). 2019 Aug; 24(8):855-862.
    View in: PubMed
    Score: 0.011
  46. Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant. Am J Transplant. 2019 01; 19(1):98-109.
    View in: PubMed
    Score: 0.011
  47. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200?days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6).
    View in: PubMed
    Score: 0.010
  48. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668.
    View in: PubMed
    Score: 0.010
  49. Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients. Pharmacotherapy. 2017 Jun; 37(6):692-699.
    View in: PubMed
    Score: 0.010
  50. Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Transplantation. 2017 Feb; 101(2):402-410.
    View in: PubMed
    Score: 0.010
  51. Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. Transplantation. 2017 Jan; 101(1):157-165.
    View in: PubMed
    Score: 0.010
  52. A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2017 01 06; 12(1):131-139.
    View in: PubMed
    Score: 0.010
  53. The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98.
    View in: PubMed
    Score: 0.010
  54. Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation. Surgery. 2017 03; 161(3):830-836.
    View in: PubMed
    Score: 0.010
  55. Twenty years of evolving trends in racial disparities for adult kidney transplant recipients. Kidney Int. 2016 10; 90(4):878-87.
    View in: PubMed
    Score: 0.010
  56. Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients. Transplantation. 2016 07; 100(7):1550-7.
    View in: PubMed
    Score: 0.009
  57. Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching. Exp Clin Transplant. 2017 Feb; 15(1):47-55.
    View in: PubMed
    Score: 0.009
  58. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86.
    View in: PubMed
    Score: 0.009
  59. A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients. Clin Transplant. 2016 05; 30(5):528-33.
    View in: PubMed
    Score: 0.009
  60. Sustainability of improvements in medication adherence through a mobile health intervention. Prog Transplant. 2015 Sep; 25(3):217-23.
    View in: PubMed
    Score: 0.009
  61. Neurocognitive status is associated with all-cause mortality among psychiatric, high-risk liver transplant candidates and recipients. Int J Psychiatry Med. 2015; 49(4):279-95.
    View in: PubMed
    Score: 0.009
  62. African American kidney transplant patients' perspectives on challenges in the living donation process. Prog Transplant. 2015 Jun; 25(2):164-75.
    View in: PubMed
    Score: 0.009
  63. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients. Pharmacotherapy. 2015 Jun; 35(6):569-77.
    View in: PubMed
    Score: 0.009
  64. Is cirrhosis a contraindication to laparoscopic cholecystectomy? Am Surg. 2015 Jan; 81(1):52-5.
    View in: PubMed
    Score: 0.009
  65. Clinical outcomes and costs associated with in-hospital biliary complications after liver transplantation: a cross-sectional analysis. J Gastrointest Surg. 2015 Feb; 19(2):282-9.
    View in: PubMed
    Score: 0.008
  66. Inflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: results of a randomized controlled trial. Transplantation. 2014 Sep 27; 98(6):632-9.
    View in: PubMed
    Score: 0.008
  67. Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis. Blood Press. 2015 Feb; 24(1):14-22.
    View in: PubMed
    Score: 0.008
  68. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. Am J Nephrol. 2014; 40(1):19-28.
    View in: PubMed
    Score: 0.008
  69. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8.
    View in: PubMed
    Score: 0.008
  70. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg. 2014 May; 259(5):888-93.
    View in: PubMed
    Score: 0.008
  71. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol. 2014 May; 9(5):960-6.
    View in: PubMed
    Score: 0.008
  72. Development and validation of a questionnaire to assess fear of kidney failure following living donation. Transpl Int. 2014 Jun; 27(6):570-5.
    View in: PubMed
    Score: 0.008
  73. Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantation. Transplantation. 2014 Mar 27; 97(6):681-5.
    View in: PubMed
    Score: 0.008
  74. Association between patient satisfaction and outcomes in kidney transplant. Am J Med Qual. 2015 Mar-Apr; 30(2):180-5.
    View in: PubMed
    Score: 0.008
  75. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91.
    View in: PubMed
    Score: 0.008
  76. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation. Clin Transplant. 2013 Mar-Apr; 27(2):274-82.
    View in: PubMed
    Score: 0.007
  77. Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J Med Internet Res. 2013 Jan 08; 15(1):e6.
    View in: PubMed
    Score: 0.007
  78. The impact of diabetes on ethnic disparities seen in kidney transplantation. Ethn Dis. 2013; 23(2):238-44.
    View in: PubMed
    Score: 0.007
  79. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant. J Cardiovasc Pharmacol Ther. 2013 May; 18(3):243-50.
    View in: PubMed
    Score: 0.007
  80. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metab. 2012 Dec; 97(12):4399-406.
    View in: PubMed
    Score: 0.007
  81. Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation. Transplant Proc. 2013 Jan-Feb; 45(1):330-4.
    View in: PubMed
    Score: 0.007
  82. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients. Transplant Proc. 2012 Jun; 44(5):1323-8.
    View in: PubMed
    Score: 0.007
  83. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011 Dec; 17(12):1394-403.
    View in: PubMed
    Score: 0.007
  84. Analyses of renal outcome following transplantation adjusting for informative right censoring and demographic factors: A longitudinal study. Ren Fail. 2010 Jul; 32(6):691-8.
    View in: PubMed
    Score: 0.006
  85. Can preemptive cytomegalovirus monitoring be as effective as universal prophylaxis when implemented as the standard of care in patients at moderate risk? Transplantation. 2010 May 27; 89(10):1218-23.
    View in: PubMed
    Score: 0.006
  86. The use of drotrecogin alfa (activated) in solid organ transplant patients: a case series. Transpl Infect Dis. 2009 Jun; 11(3):269-76.
    View in: PubMed
    Score: 0.006
  87. Laparoscopic hepatic resection: the MUSC experience. J S C Med Assoc. 2008 Dec; 104(8):244-6.
    View in: PubMed
    Score: 0.006
  88. Does bioequivalence between modified cyclosporine formulations translate into equal outcomes? Transplantation. 2005 Dec 15; 80(11):1633-5.
    View in: PubMed
    Score: 0.005
  89. Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis. 2004 Sep; 6(3):101-9.
    View in: PubMed
    Score: 0.004
  90. Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg. 2003 Dec; 7(8):1096-101.
    View in: PubMed
    Score: 0.004
  91. Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. Nephrol Dial Transplant. 2003 Nov; 18(11):2436-8.
    View in: PubMed
    Score: 0.004
  92. Further improvements in laparoscopic donor nephrectomy: decreased pain and accelerated recovery. Clin Transplant. 2001; 15 Suppl 6:59-61.
    View in: PubMed
    Score: 0.003
  93. Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology. 1996 Sep; 111(3):710-5.
    View in: PubMed
    Score: 0.002
  94. The effects of prostaglandin E1 on hepatic allograft vascular inflow: a prospective randomized double-blind study. Am Surg. 1996 Mar; 62(3):184-7.
    View in: PubMed
    Score: 0.002
  95. Failure of dialysis access: revise or replace? J Surg Res. 1996 Feb 01; 60(2):312-6.
    View in: PubMed
    Score: 0.002
  96. Avulsion of the right facial vein during double cannulation of the internal jugular vein. J Cardiothorac Vasc Anesth. 1995 Aug; 9(4):429-30.
    View in: PubMed
    Score: 0.002
  97. Stress steroids are not required for patients receiving a renal allograft and undergoing operation. J Am Coll Surg. 1995 May; 180(5):532-6.
    View in: PubMed
    Score: 0.002
  98. New patterns of transplant nephrectomy in the cyclosporine era. J Am Coll Surg. 1994 Jan; 178(1):59-64.
    View in: PubMed
    Score: 0.002
  99. Renal dysfunction in hepatic disease: early identification with renal duplex Doppler US in patients who undergo liver transplantation. Radiology. 1992 Jun; 183(3):801-6.
    View in: PubMed
    Score: 0.002
  100. Early immunological benefits of glutathione-supplemented UW solution in hepatic transplantation. Transplant Proc. 1991 Aug; 23(4):2243-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.